Vincent mangematin
Vincent mangematin
Verified email at
Cited by
Cited by
Business models: A challenging agenda
C Baden-Fuller, V Mangematin
Strategic Organization 11 (4), 418-427, 2013
From recipe to dinner: business model portfolios in the European biopharmaceutical industry
V Sabatier, V Mangematin, T Rousselle
Long Range Planning 43 (2-3), 431-447, 2010
PhD job market: professional trajectories and incentives during the PhD
V Mangematin
Research policy 29 (6), 741-756, 2000
What kind of knowledge can a firm absorb?
V Mangematin, L Nesta
International Journal of Technology Management 18 (3-4), 149-172, 1999
Technological knowledge base, R&D organization structure and alliance formation: Evidence from the biopharmaceutical industry
J Zhang, C Baden-Fuller, V Mangematin
Research policy 36 (4), 515-528, 2007
University technology transfer offices: The search for identity to build legitimacy
C O’kane, V Mangematin, W Geoghegan, C Fitzgerald
Research Policy 44 (2), 421-437, 2015
When technological discontinuities and disruptive business models challenge dominant industry logics: Insights from the drugs industry
V Sabatier, A Craig-Kennard, V Mangematin
Technological Forecasting and Social Change 79 (5), 949-962, 2012
Development of SMEs and heterogeneity of trajectories: the case of biotechnology in France
V Mangematin, S Lemarié, JP Boissin, D Catherine, F Corolleur, ...
Research Policy 32 (4), 621-638, 2003
Technological agglomeration and the emergence of clusters and networks in nanotechnology
DKR Robinson, A Rip, V Mangematin
Research policy 36 (6), 871-879, 2007
Orchestrating innovation with user communities in the creative industries
G Parmentier, V Mangematin
Technological forecasting and social change 83, 40-53, 2014
Collaboration, creativity and rewards: why and how scientists collaborate
G Laudel
International Journal of Technology Management 22 (7-8), 762-781, 2001
Profile of public laboratories, industrial partnerships and organisation of R & D: the dynamics of industrial relationships in a large research organisation
PB Joly, V Mangematin
Research policy 25 (6), 901-922, 1996
Understanding the emergence and deployment of “nano” S&T
B Bozeman, P Laredo, V Mangematin
Research policy 36 (6), 807-812, 2007
Is the creation and development of biotech SMEs localised? Conclusions drawn from the French case
S Lemarié, V Mangematin, A Torre
Small business economics 17 (1), 61-76, 2001
Disassembly and reassembly: An introduction to the Special Issue on digital technology and creative industries
V Mangematin, J Sapsed, E Schüßler
Technological Forecasting and Social Change 83, 1-9, 2014
Seed accelerators and the speed of new venture creation
J Stayton, V Mangematin
The Journal of Technology Transfer 44, 1163-1187, 2019
The future of nanotechnologies
V Mangematin, S Walsh
Technovation 32 (3-4), 157-160, 2012
Profiles of academic activities and careers: Does gender matter? An analysis based on French life scientist CVs
M Sabatier, M Carrere, V Mangematin
The Journal of Technology Transfer 31, 311-324, 2006
La confiance: approches économiques et sociologiques
C Thuderoz, V Mangematin, D Harrisson
G. Morin, 1999
Turning scientific and technological human capital into economic capital: the experience of biotech start-ups in France
CDF Corolleur, M Carrere, V Mangematin
Research Policy 33 (4), 631-642, 2004
The system can't perform the operation now. Try again later.
Articles 1–20